Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired_by |
gptkb:Emergent_Bio_Solutions
|
| gptkbp:advances |
in opioid overdose treatment
|
| gptkbp:advocacy |
for naloxone access
for naloxone legislation |
| gptkbp:awards |
industry recognition
|
| gptkbp:clinical_trial |
ongoing research
|
| gptkbp:collaboration |
public health initiatives
with law enforcement |
| gptkbp:collaborations |
with universities
|
| gptkbp:community_engagement |
active participation
|
| gptkbp:community_involvement |
to promote awareness
|
| gptkbp:community_outreach |
education on opioid overdose
|
| gptkbp:community_programs |
to reduce stigma
|
| gptkbp:distribution |
pharmacies and hospitals
|
| gptkbp:educational_resources |
for healthcare providers
|
| gptkbp:financial_support |
programs available
|
| gptkbp:focus |
opioid overdose treatment
|
| gptkbp:focus_area |
substance use disorder
|
| gptkbp:founded |
gptkb:2014
|
| gptkbp:founder |
gptkb:Seamus_Mulligan
|
| gptkbp:funding |
for opioid crisis solutions
|
| gptkbp:future_plans |
to expand product offerings
|
| gptkbp:headquarters |
gptkb:Radnor,_Pennsylvania
|
| https://www.w3.org/2000/01/rdf-schema#label |
Adapt Pharma
|
| gptkbp:impact |
on public health policy
|
| gptkbp:innovation |
in overdose response
|
| gptkbp:investment |
in drug development
|
| gptkbp:is_committed_to |
to public health
|
| gptkbp:leadership |
experienced pharmaceutical executives
|
| gptkbp:market |
gptkb:North_America
|
| gptkbp:market_position |
nationwide
|
| gptkbp:marketing_strategy |
focused on accessibility
|
| gptkbp:mission |
to save lives from opioid overdose
|
| gptkbp:network |
of healthcare professionals
|
| gptkbp:number_of_employees |
approximately 100
|
| gptkbp:partnership |
various healthcare organizations
|
| gptkbp:partnerships |
with educational institutions
with non-profits |
| gptkbp:philanthropy |
supporting addiction recovery programs
|
| gptkbp:product |
gptkb:Narcan
|
| gptkbp:product_impact |
significant in reducing fatalities
|
| gptkbp:product_line |
expanding
|
| gptkbp:reach |
increasing
|
| gptkbp:regulatory_compliance |
gptkb:various_countries
navigated successfully stringent standards |
| gptkbp:research |
opioid addiction treatment
|
| gptkbp:safety_features |
well-established
|
| gptkbp:social_responsibility |
commitment to public health.
|
| gptkbp:strategic_goals |
focused on accessibility
|
| gptkbp:supply_chain |
efficient and reliable
|
| gptkbp:support |
for families affected by addiction
|
| gptkbp:training |
for first responders
|
| gptkbp:type |
private company
|
| gptkbp:website |
www.adaptpharma.com
|
| gptkbp:bfsParent |
gptkb:Emergent_Bio_Solutions
|
| gptkbp:bfsLayer |
6
|